Listed

Belite Bio, Inc

BLTENasdaqCIK 1889109HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Balance sheet

Cash and equivalents$352.9m, FY2025
Shareholders' equity$770.5m, FY2025
Line itemUnitperiod not labelled2019-12-31period not labelled2020-12-31period not labelled2021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31
Cash and equivalents$mnot reportednot reported17.3Cash and equivalents, period not labelled, at 2021-12-31$17.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 20-F filed 2023-03-31, accession 0001104659-23-040145.Report this figure42.1Cash and equivalents, FY2022, at 2022-12-31$42.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 20-F filed 2024-03-12, accession 0001104659-24-033149.Report this figure88.2Cash and equivalents, FY2023, at 2023-12-31$88.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 20-F filed 2025-03-17, accession 0001410578-25-000356.Report this figure31.7Cash and equivalents, FY2024, at 2024-12-31$31.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 20-F filed 2026-03-31, accession 0001104659-26-037374.Report this figure353Cash and equivalents, FY2025, at 2025-12-31$352.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 20-F filed 2026-03-31, accession 0001104659-26-037374.Report this figure
Current assets$mnot reportednot reported17.4Current assets, period not labelled, at 2021-12-31$17.4m. XBRL concept us-gaap:AssetsCurrent. 20-F filed 2023-03-31, accession 0001104659-23-040145.Report this figure42.8Current assets, FY2022, at 2022-12-31$42.8m. XBRL concept us-gaap:AssetsCurrent. 20-F filed 2024-03-12, accession 0001104659-24-033149.Report this figure89.9Current assets, FY2023, at 2023-12-31$89.9m. XBRL concept us-gaap:AssetsCurrent. 20-F filed 2025-03-17, accession 0001410578-25-000356.Report this figure147Current assets, FY2024, at 2024-12-31$147.1m. XBRL concept us-gaap:AssetsCurrent. 20-F filed 2026-03-31, accession 0001104659-26-037374.Report this figure494Current assets, FY2025, at 2025-12-31$494.3m. XBRL concept us-gaap:AssetsCurrent. 20-F filed 2026-03-31, accession 0001104659-26-037374.Report this figure
Total assets$mnot reportednot reported18.3Total assets, period not labelled, at 2021-12-31$18.3m. XBRL concept us-gaap:Assets. 20-F filed 2023-03-31, accession 0001104659-23-040145.Report this figure44.3Total assets, FY2022, at 2022-12-31$44.3m. XBRL concept us-gaap:Assets. 20-F filed 2024-03-12, accession 0001104659-24-033149.Report this figure94.6Total assets, FY2023, at 2023-12-31$94.6m. XBRL concept us-gaap:Assets. 20-F filed 2025-03-17, accession 0001410578-25-000356.Report this figure152Total assets, FY2024, at 2024-12-31$152.1m. XBRL concept us-gaap:Assets. 20-F filed 2026-03-31, accession 0001104659-26-037374.Report this figure781Total assets, FY2025, at 2025-12-31$780.6m. XBRL concept us-gaap:Assets. 20-F filed 2026-03-31, accession 0001104659-26-037374.Report this figure
Current liabilities$mnot reportednot reported1.6Current liabilities, period not labelled, at 2021-12-31$1.6m. XBRL concept us-gaap:LiabilitiesCurrent. 20-F filed 2023-03-31, accession 0001104659-23-040145.Report this figure2.1Current liabilities, FY2022, at 2022-12-31$2.1m. XBRL concept us-gaap:LiabilitiesCurrent. 20-F filed 2024-03-12, accession 0001104659-24-033149.Report this figure3.6Current liabilities, FY2023, at 2023-12-31$3.6m. XBRL concept us-gaap:LiabilitiesCurrent. 20-F filed 2025-03-17, accession 0001410578-25-000356.Report this figure6.1Current liabilities, FY2024, at 2024-12-31$6.0m. XBRL concept us-gaap:LiabilitiesCurrent. 20-F filed 2026-03-31, accession 0001104659-26-037374.Report this figure9.9Current liabilities, FY2025, at 2025-12-31$9.9m. XBRL concept us-gaap:LiabilitiesCurrent. 20-F filed 2026-03-31, accession 0001104659-26-037374.Report this figure
Total liabilities$mnot reportednot reported1.6Total liabilities, period not labelled, at 2021-12-31$1.6m. XBRL concept us-gaap:Liabilities. 20-F filed 2023-03-31, accession 0001104659-23-040145.Report this figure2.8Total liabilities, FY2022, at 2022-12-31$2.8m. XBRL concept us-gaap:Liabilities. 20-F filed 2024-03-12, accession 0001104659-24-033149.Report this figure4.2Total liabilities, FY2023, at 2023-12-31$4.2m. XBRL concept us-gaap:Liabilities. 20-F filed 2025-03-17, accession 0001410578-25-000356.Report this figure6.3Total liabilities, FY2024, at 2024-12-31$6.3m. XBRL concept us-gaap:Liabilities. 20-F filed 2026-03-31, accession 0001104659-26-037374.Report this figure10.1Total liabilities, FY2025, at 2025-12-31$10.1m. XBRL concept us-gaap:Liabilities. 20-F filed 2026-03-31, accession 0001104659-26-037374.Report this figure
Shareholders' equity$m(3.7)Shareholders' equity, period not labelled, at 2019-12-31−$3.7m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2023-03-31, accession 0001104659-23-040145.Report this figure(7.0)Shareholders' equity, period not labelled, at 2020-12-31−$7.0m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2024-03-12, accession 0001104659-24-033149.Report this figure(15.1)Shareholders' equity, period not labelled, at 2021-12-31−$15.1m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2025-03-17, accession 0001410578-25-000356.Report this figure41.5Shareholders' equity, FY2022, at 2022-12-31$41.5m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2026-03-31, accession 0001104659-26-037374.Report this figure90.4Shareholders' equity, FY2023, at 2023-12-31$90.4m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2026-03-31, accession 0001104659-26-037374.Report this figure146Shareholders' equity, FY2024, at 2024-12-31$145.8m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2026-03-31, accession 0001104659-26-037374.Report this figure770Shareholders' equity, FY2025, at 2025-12-31$770.5m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2026-03-31, accession 0001104659-26-037374.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.